Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0767 and Sulfonylurea Combination Study
NCT00543491Phase 3Terminated
- Sponsor
- Merck & Co.
- Start
- May 2003
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing MK0767 + Sulfonylurea with Placebo + Sulfonylurea (2 arms). Started May 2003; status: terminated.
02
Drugs
MK-767
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00543491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543491.